Keytruda

Pembrolizumab

7.0 High risk

Keytruda & Malignant neoplasm progression

7.7%

of users reported Malignant neoplasm progression

65.0%

also reported Severe reaction

63.8%

are men

Most common medical consequences

Severe reaction
65.0%
Death
25.9%
Hospitalization
7.0%
Life-threatening condition
1.6%
Disability
0.4%

Have you experienced any negative side effects from this medication?

Keytruda: general information

Most common side effects (491)

Most commonly affected ages

10 - 19 years
0.1%
20 - 29 years
0.9%
30 - 39 years
2.5%
40 - 49 years
6.1%
50 - 59 years
16.0%
60 - 69 years
30.9%
70 - 79 years
32.7%
80 - 89 years
10.1%
90 - 99 years
0.6%
On this page
Keytruda & Malignant neoplasm progression
Keytruda: general information